FDA, DOJ Push Back In Case That Seeks To Rescind Abortion Pill Approval

By Beth Wang / January 18, 2023 at 8:06 PM
FDA and the Justice Department are pushing back on a first-of-its-kind lawsuit that seeks to scrap FDA’s approval of the abortion pill mifepristone. The agencies on Wednesday (Jan. 18) filed an opposition statement with a Texas court, arguing that withdrawing approval of mifepristone would cause worse health outcomes for patients who rely on mifepristone to safely and effectively terminate their pregnancies and interfere with Congress’ decision to entrust FDA with responsibility to ensure the safety and efficacy of drugs. Plaintiffs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.